INNOVADERM CRO IS NOW INDERO.

Acne Case Study

Indero

Indero

Team of Experts

Author picture

Outcomes

  • Innovaderm successfully managed this acne study and this resulted in enrollment completed 1 month earlier than planned

Study Characteristics

  • Study Phase: II
  • Patient Population: Acne vulgaris (enrolling pediatrics & adults)
  • IP Route of Administration: Systemic
  • Sites distribution: 15 sites (USA)

Study Challenges and Solutions

Challenge 1: Administration Mode

Use of a novel route of administration for a population accustomed to topical and oral treatments

Solutions

  • Promoting the new treatment and clarity of messaging with the sites
  • Careful selection of sites

Outcome

  • Enrollment completed one month ahead of schedule

Challenge 2: Recruitment – Apprehension

  • Enrollment of pediatric population while managing patients’ and their parents’ fears regarding the route of administration

Solutions

  • Experience with pediatric enrollment was mandatory for sites
  • As minors tend to have compliance issues, the administration of a drug once every two weeks was a key advantage

Outcome

  • Recruited much more pediatrics than expected (+40%)

Challenge 3: Pandemic

  • Enrolling during the first waves of COVID-19 could have impacted recruitment & operations (site staffing, monitoring visits, etc.)

Solutions

  • Sites were prepared to operate and follow new safety guidelines regarding COVID-19

Outcome

  • The study proceeded as scheduled

Key Success Factors & Strategies

  • Local advertisement campaigns to increase engagement
  • Implemented remote monitoring during COVID-19 to maintain workflow efficiency
SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.